The Change of Serum Soluble E-selectin in Kawasaki Disease

가와사끼병에서의 혈청 Soluble E-selectin의 변화

  • Jeong, Jae-Ho (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Cho, Eun-Young (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Lim, Jae-Woo (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Cheon, Eun-Jeong (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Ko, Kyong-Og (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Lee, Kyung-Il (Department of Pediatrics, College of Medicine, The Catholic of University Korea)
  • 정재호 (건양대학교 의과대학 소아과학교실) ;
  • 조은영 (건양대학교 의과대학 소아과학교실) ;
  • 임재우 (건양대학교 의과대학 소아과학교실) ;
  • 천은정 (건양대학교 의과대학 소아과학교실) ;
  • 고경옥 (건양대학교 의과대학 소아과학교실) ;
  • 이경일 (가톨릭대학교 의과대학 소아과학교실)
  • Received : 2004.12.29
  • Accepted : 2005.03.07
  • Published : 2005.05.15

Abstract

Purpose : The aim of this study was to investigate the pathophysiologic role of serum E-selectin, vascular endothelial growth factor(VEGF)-induced cell adhesion mollecule in Kawasaki disease(KD) and to look for the evidence of direct relationship between the plasma levels of soluble E-selectin and the incidence of coronary artery lesion(CAL). Methods : Changes in plasma levels of sE-selectin(n=98) over time were measured by enzyme-linked immunosorbent assay(ELISA) in 23 patients with acute KD and 25 age-matched febrile children. Results : Compared with control values, the peak levels of plasma sE-selectin were significantly elevated($mean{\pm}S.E$. : $22.89{\pm}12.53ng/mL$ vs $10.65{\pm}3.42ng/mL$, P=0.01) in KD. 5 patients with CAL, plasma sE-selectin levels before treatment were higher than in 18 patients without CAL($mean{\pm}S.E$. : $39.43{\pm}15.08ng/mL$ and $19.00{\pm}8.32ng/mL$, respectively; P=0.01). Plasma sE-selectin declined rapidly in the majority of KD patients regardless of the presence of CAL. Plasma sE-selectin levels after treatment and convalesent period were similar in KD patients with and without CAL. The plasma levels sE-selectin were correlated with those of white blood cell count(r=0.299, P<0.05), CRP(r=0.430, P<0.05), serum albumin(r=-0.483, P<0.05), serum protein(r=-0.502, P<0.05) and hemoglobin(r=-0.372, P<0.05) not with those of ESR, platelet, or duration of fever. There were significant differences in the initial level of serum sE-selectin between KD with and without CAL($mean{\pm}S.E$. : $39.44{\pm}15.08ng/mL$ vs. $19.00{\pm}17.18ng/mL$) in multivariated linear tests. Conclusion : Plasma sE-selectin levels were significantly higher in KD than in other febrile illness. Higher plamsa levels of sE-selectin may have potential as a predictor of CAL in patients with KD.

목 적 : 일반적인 혈관염에서의 sE-selectin의 역할을 고려할 때 가와사끼병에서도 중요한 역할을 할 것으로 예측하였다. 이에 가와사끼병의 진단지표로서의 가치 및 관상동맥병변의 합병을 예측하는 인자로서의 가능성이 있는지를 알아보고자 하였다. 방 법 : 1999년 1월부터 2004년 8월까지 건양대학교병원과 대전성모병원에 열성질환으로 입원한 환아 중 25명을 대조군으로 하였으며 같은 기간에 가와사끼병으로 입원하여 면역글로불린 치료를 받은 환아 23명을 대상으로 하여 관상동맥병변을 보인 5명과 보이지 않은 18명으로 나누었으며 치료 전, 면역글로불린 투여 후 2일, 2주, 4주째에 혈액을 채취해 효소면역측정법(ELISA)을 통해 혈청 sE-selectin 농도를 측정하였다. 결 과 : 1) 치료 전의 혈청 sE-selectin 농도는 가와사끼병 환자군에서 $22.89{\pm}12.53ng/mL$로 대조군의 $10.65{\pm}3.42ng/mL$에 비해 통계학적으로 유의하게 상승되어 있었다. 2) 가와사끼병 환자군에서 혈청 sE-selectin의 농도는 면역글로불린 투여 이후 급격히 감소하는 경향을 보였으며 이는 관상동맥병변의 유무에 따른 차이를 보이지 않았다. 3) 혈청 sE-selectin 농도는 다른 염증지표들 중 백혈구, CRP, 혈색소, 단백질, 알부민과 역상관관계를 보였으며, 그 외 ESR, 혈소판, 발열기간과는 유의한 상관관계를 보이지 않았다. 4) 가와사끼병 환자들 중 관상동맥병변에 대한 위험요인을 분석한 결과 치료 전의 혈청 sE-selectin과 혈색소치가 통계적으로 유의한 위험요인으로 나타났다($39.44{\pm}15.08ng/mL$ vs.$19.00{\pm}17.18ng/mL$, $9.98{\pm}0.46g/dL$ vs. $10.98{\pm}0.78g/d$L). 결 론: 가와사끼병 환자에서 혈청 sE-selectin은 다른 열성 질환에 비해 의미있게 상승하는 것으로 나타나 감별진단에 도움이 될 것으로 생각되며 특히, 관상동맥병변의 합병을 예측하는 인자로서의 가능성을 보였다.

Keywords

Acknowledgement

Supported by : 명곡 임상의학 연구기금

References

  1. Suzuki A, Karniya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1994;74:822-44 https://doi.org/10.1016/0002-9149(94)90446-4
  2. Kato H, Augiy ama T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. Circulation 1996;94:1379-85 https://doi.org/10.1161/01.CIR.94.6.1379
  3. Cuttica RJ. Vasculitis, Kawasaki disease and pseudovasculitis. CUIT Opinion Rheumatol 1997;9:448-57 https://doi.org/10.1097/00002281-199709000-00012
  4. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7
  5. Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease with particular emphasis on arterial lesion. Acta Pathol Jpn 1991;41:785-97
  6. Chrisopher GK, Daniel CB. Roles of Leukocyte!Endothelial cell adhesion molecules in the pathogenesis of vasculitis. Am J Med 1999;106:677-87 https://doi.org/10.1016/S0002-9343(99)00132-1
  7. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994:45:361-78 https://doi.org/10.1146/annurev.med.45.1.361
  8. McEver RP. Selectins. CUIT Opin Immunol 1994;6:75-84 https://doi.org/10.1016/0952-7915(94)90037-X
  9. Killip T, Fisher LD, Moch MB. National heart, lung and blood institute coronary artery surgery study(CASS). Circulation 1981;64:1-8l https://doi.org/10.1161/01.CIR.64.1.1
  10. Pak YW. Epidemiology of Kawasaki disease. 2004 May 9; Seoul. Symposium of Kawasaki Disease 2004:1-6
  11. Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID, et al. Kawasaki syndrome: description of two outbreaks in United States. N Engl J Med 1981;304:1568-75 https://doi.org/10.1056/NEJM198106253042603
  12. Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J 1999;18: 69-70 https://doi.org/10.1097/00006454-199901000-00018
  13. Shulman ST, Rowely AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986;2:545-6
  14. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, et al. The abscence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995;172:558-61 https://doi.org/10.1093/infdis/172.2.558
  15. Kohsaki T, Abe J. Asahina T, Kobayashi N. Classical pathway complement activation in Kawasaki syndrome. J Allergy Clin Immunol 1994;93:520-5 https://doi.org/10.1016/0091-6749(94)90362-X
  16. Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann LR. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 2001;21:193-9 https://doi.org/10.1023/A:1011039216251
  17. Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998:44:596-9 https://doi.org/10.1203/00006450-199810000-00021
  18. Schiller B, Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease.relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr 1999;88:844-8 https://doi.org/10.1080/08035259950168766
  19. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997;108:446-50 https://doi.org/10.1046/j.1365-2249.1997.3852128.x
  20. Andrew B, Julie M, Charles M. Soluble L-selectin in peripheral arterial disease.relationship with soluble E-selectin and soluble P-selectin. Atherosclerosis 1996;126:227-3l https://doi.org/10.1016/0021-9150(96)05911-4
  21. Kim DS, Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 1994;23:283-6 https://doi.org/10.3109/03009749409103730
  22. Kawasaki T. General review and problems m Kawasaki disease. Jpn Heart J 1995;36:1-12 https://doi.org/10.1536/ihj.36.1
  23. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997;108:446-50 https://doi.org/10.1046/j.1365-2249.1997.3852128.x
  24. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Pediatr Jpn 1991;33:805-10 https://doi.org/10.1111/j.1442-200X.1991.tb02612.x
  25. Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, et al. Changes of P-selectin and E-selectin in children with Kawasaki disease. Zhonghua Er Ke Za Zhi 2004:42:688-92
  26. Furui J, Ishii M, Ikedas H, Muta H, Egami K, Sugahara Y, et al. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions. Acta Paediatr 2002;91:1183-8 https://doi.org/10.1080/080352502320777414
  27. Takuro O, Hisaji I, Kazuhiko I, Kouhei A, Kunitaka J, Toshiro H. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-9 https://doi.org/10.1007/s004310051300